Here's Why BioNTech Gained 34.8% in June

Here's Why BioNTech Gained 34.8% in June

Shares of BioNTech (NASDAQ: BNTX) rose 34.8% last month, according to data provided by S&P Global Market Intelligence. The German biopharma announced progress in efforts to develop a safe and effective vaccine against SARS-CoV-2, the coronavirus that causes COVID-19, with partner Pfizer. In mid-June, BioNTech announced it had received access to roughly $112 million in debt financing from the European Investment Bank.